Organization: Health Canada
Year: 2022
Month: December
Request Number: A-2022-000816
Request Summary: The most current Canadian Risk Management Plan (RMP) or Canadian Addendum to the RMP and Canadian RMP review report for NEUPOGEN by Amgen Canada Inc., Drug Identification Numbers (DINs) 01968017, 02420104, and 02420112.
Disposition: Disclosed in part
Number of pages: 123